Zurich Cantonal Bank
LYEL icon

Zurich Cantonal Bank’s Lyell Immunopharma LYEL Stock Holding History

Zurich Cantonal Bank’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7K Buy
905
+458
+102% +$8.29K ﹤0.01% 2488
2026
Q1 		$8.97K Buy
+447
New +$10.4K ﹤0.01% 2487
2024
Q4 		– Sell
-1,496
Closed -$41.3K – 2666
2024
Q3 		$41.3K Hold
1,496
– – ﹤0.01% 2571
2024
Q2 		$43.4K Hold
1,496
– – ﹤0.01% 2556
2024
Q1 		$66.7K Hold
1,496
– – ﹤0.01% 2511
2023
Q4 		$58K Sell
1,496
-331
-18% -$11.9K ﹤0.01% 2584
2023
Q3 		$53.7K Hold
1,827
– – ﹤0.01% 2581
2023
Q2 		$116K Buy
+1,827
New +$101K ﹤0.01% 2273

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Zurich Cantonal Bank's LYEL Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Lyell Immunopharma (LYEL) stake by 102% in Q2 2026, buying an estimated $8.29K and bringing the position to 905 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Zurich Cantonal Bank first reported a position in LYEL in Q2 2023 and has held it in 8 quarters since. The position peaked at $116K in Q2 2023. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Zurich Cantonal Bank held 905 shares of Lyell Immunopharma worth $12.7K as of Q2 2026.
  • Zurich Cantonal Bank bought 458 Lyell Immunopharma shares in Q2 2026, an estimated $8.29K.
  • Lyell Immunopharma made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2488 holding.
  • Zurich Cantonal Bank first reported a position in Lyell Immunopharma in Q2 2023 and has held it in 8 quarters since.
  • Zurich Cantonal Bank's Lyell Immunopharma position peaked at $116K in Q2 2023.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.